The American Medical Association (AMA) said this week that its delegates are working to stop implementation of ICD-10.
"The implementation of ICD-10 will create significant burdens on the practice of medicine with no direct benefit to individual patients' care," Peter W. Carmel, M.D., AMA president said in a prepared statement.
Citing a 2008 study, AMA explained that projected costs of converting to the unfunded code sets mandate will cost even a three-physician practice $84,000 and slightly more than $285,000 for a 10-physician group.
As part of its statement, AMA explained that it “will continue working to help physicians keep their focus where it should be — on their patients."

Read the full story at: http://www.healthcarefinancenews.com/news/ama-pushes-back-icd-10
Sources: Health Finance News; American Medical Association
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More